Concall Intelligence
Follow the Sept 2026 quarter results season by comparing what companies reported with what management said next. Search official call evidence, measurable guidance, changing outlook, operating risks, and prior commitments without treating commentary as a trading recommendation.
Management evidence
Generated 22 Oct, 5:44 am IST · click a summary to inspect source-linked evidence for this results quarter.
| Company | Call and sources | Reported result | Management outlook | Evidence-led conclusion | Review |
|---|---|---|---|---|---|
| TARIL Transformers And Rectifiers (India) Limited Industrials · Large | Sept 2026 21 Oct 2026 Transcript filed | Excellent 100/100 | Outlook pending No comparable prior call Guidance pending | The available source has not produced sufficient structured evidence. Summary pending | |
| TECHM Tech Mahindra Limited IT · Large | Sep 2026 21 Oct 2026 Transcript verified | Excellent 80/100 | Optimistic outlook Broadly unchanged No measurable guidance | Tech Mahindra delivered strong revenue and profit growth, highlighted AI and vertical wins, and expressed confidence in sustaining momentum into the December quarter. Evidence summary ready | |
| INDIANB Indian Bank Financial Services · Mid | Sept 2026 21 Oct 2026 Transcript verified | Good 60/100 | Optimistic outlook Broadly unchanged Guidance raised | Indian Bank reported a strong set of results for Q2 FY27 with net profit growing 14.71% YoY to Rs.3,462 crore (aided by NSE listing gains), healthy advances growth of 16.39%, and improving asset quality metrics with GNPA at 1.61%. Management has revised its deposit and advances growth guidance upwards for the full year while acknowledging potential headwinds from regulatory changes, potential HTM valuation shocks, and credit cost normalisation under ECL models. Evidence summary ready | |
| 360ONE 360 ONE WAM LIMITED Financial Services · Mid | Sept 2026 21 Oct 2026 Transcript verified | Bad 0/100 | Cautious outlook Broadly unchanged No measurable guidance | Quarterly results showed modest revenue growth and a decline in profit, while management highlighted strong AUM growth, improved ARR retention, and long‑term profitability targets, but flagged margin pressure from higher costs and reliance on UBS flow execution. Evidence summary ready | |
| CCL CCL Products (India) Limited FMCG · Large | Sept 2026 21 Oct 2026 Transcript verified | Average 47/100 | Optimistic outlook Broadly unchanged Guidance maintained | CCL delivered strong Q2 results with double‑digit volume growth and profit expansion, and management reaffirmed its FY27 guidance of ~15% volume and EBITDA growth, while noting coffee price volatility and capacity considerations. Evidence summary ready | |
| EMMVEE Emmvee Photovoltaic Power Limited Industrials · Large | Sep 2026 21 Oct 2026 Transcript verified | Good 67/100 | Optimistic outlook No comparable prior call Guidance maintained | Emmvee delivered strong Q2 FY27 results with double‑digit revenue and profit growth, maintained high margins, and indicated that its expansion projects are on schedule, but future finance costs will rise post‑commissioning. Evidence summary ready | |
| ARSSBL Anand Rathi Share and Stock Brokers Limited Financial Services · Small | Sept 2026 21 Oct 2026 Transcript verified | Excellent 77/100 | Optimistic outlook Broadly unchanged Guidance maintained | Anand Rathi Share and Stock Brokers Limited delivered a robust financial performance in Q2 FY27, reporting strong year-on-year growth in revenue and PAT supported by expansion in the Margin Trading Facility (MTF) and distribution businesses, despite a turbulent secondary market. Evidence summary ready | |
| SHOPERSTOP Shoppers Stop Limited Consumer · Small | Sep 2026 21 Oct 2026 Transcript verified | Bad 22/100 | Optimistic outlook No comparable prior call Guidance raised | Shoppers Stop delivered modest top‑line growth and a turnaround to profitability, driven by strong festive demand, premiumisation initiatives and new store openings, while highlighting ongoing work on inventory and working‑capital optimisation. Evidence summary ready | |
| DBCORP D.B.Corp Limited Media · Small | Sept 2026 21 Oct 2026 Transcript verified | Bad 0/100 | Optimistic outlook Broadly unchanged Guidance maintained | D.B. Corp reported a decline in Q2 FY27 revenue and PAT due to the festive season (Navaratra) shifting into Q3 and temporary headwinds such as panchayat election codes of conduct, though underlying advertising and EBITDA registered positive single-digit growth on a like-to-like basis. Evidence summary ready | |
| E2E E2E Networks Limited IT · Small | Sept 2026 21 Oct 2026 Transcript verified | Good 55/100 | Optimistic outlook Broadly unchanged No measurable guidance | E2E Networks delivered robust financial performance in Q2 FY27 with triple-digit YoY revenue growth and margin expansion, supported by Blackwell GPU deployment and improved utilization. Management maintains a disciplined approach to capex and avoids speculative guidance. Evidence summary ready | |
| ICICIPRULI ICICI Prudential Life Insurance Company Limited Financial Services · Large | Sep 2026 21 Oct 2026 Transcript verified | Good 65/100 | Optimistic outlook No comparable prior call No measurable guidance | ICICI Life delivered solid revenue and profit growth despite macro volatility, with strong VNB expansion and margin stability, while emphasizing continued investment in agency distribution and upcoming regulatory reforms. Evidence summary ready | |
| SGFIN SG Finserve Limited Financial Services · Small | Sep 2026 21 Oct 2026 Transcript verified | Excellent 80/100 | Cautious outlook No comparable prior call New guidance | SG Finserve delivered strong Q2 FY27 results with record PAT and loan book growth, but management plans to increase leverage to 4x and targets 30‑35% AUM growth YoY, introducing execution and capital‑raising considerations. Evidence summary ready | |
| ANGELONE Angel One Limited Financial Services · Small | Sept 2026 21 Oct 2026 Transcript verified | Excellent 90/100 | Optimistic outlook Broadly unchanged Guidance maintained | Angel One delivered resilient Q2 FY27 results with consolidated revenue of 14.3 billion rupees and PAT of 3.35 billion rupees despite subdued capital market volumes. Operating margins expanded significantly year-over-year, supported by operating leverage and a diversified revenue mix. Evidence summary ready | |
| HDFCAMC HDFC Asset Management Company Limited Financial Services · Large | Sept 2026 21 Oct 2026 Transcript verified | Good 55/100 | Optimistic outlook Broadly unchanged No measurable guidance | HDFC Asset Management delivered solid revenue growth and maintained high profitability, while highlighting continued expansion of SIP inflows, alternative platform launches, and disciplined cost management; however, guidance on future revenue mix and margins remains limited. Evidence summary ready | |
| BAJAJCON Bajaj Consumer Care Limited Consumer · Small | Sept 2026 21 Oct 2026 Transcript verified | Excellent 90/100 | Optimistic outlook Broadly unchanged No measurable guidance | Bajaj Consumer Care delivered a resilient performance in Q2 FY27 amid raw material volatility, reporting double-digit unit volume growth in its core Almond Drops franchise and maintaining strong EBITDA and PAT margins through fixed cost efficiencies. Evidence summary ready | |
| TIPSMUSIC Tips Music Limited Media · Micro | Sept 2026 21 Oct 2026 Transcript verified | Good 62/100 | Optimistic outlook Broadly unchanged Guidance raised | Tips Music delivered strong top‑line and profit growth in Q2 FY27, driven by new releases and catalog performance across digital and non‑digital platforms. Management upgraded FY27 growth guidance but highlighted a front‑loaded content spend, ongoing YouTube Shorts negotiations and a smaller‑film focus for H2. Evidence summary ready | |
| HDBFS HDB Financial Services Limited Financial Services · Large | Sept 2026 20 Oct 2026 Transcript verified | Good 55/100 | Optimistic outlook Broadly unchanged No measurable guidance | HDB Financial Services delivered strong top‑line and profit growth in Q2 FY27, driven by robust disbursements across enterprise and consumer segments, improved asset quality and margins, and continued capital strength. Management is optimistic about H2, citing festive demand and capacity to scale, but flags monsoon‑related inflation, seasonal asset‑quality pressures and regulatory fee uncertainties as risks. Evidence summary ready | |
| LOTUSDEV Sri Lotus Developers and Realty Limited Real Estate · Micro | Sept 2026 19 Oct 2026 Transcript verified | Excellent 100/100 | Optimistic outlook Broadly unchanged New guidance | Sri Lotus delivered strong revenue and profit growth in Q2 FY27, with robust pre‑sales and expanding margins, while management signals confidence in H2 launches and FY27 targets, albeit with execution and pricing risks. Evidence summary ready | |
| HERITGFOOD Heritage Foods Limited FMCG · Micro | Sept 2026 19 Oct 2026 Transcript verified | Bad 0/100 | Cautious outlook Broadly unchanged No measurable guidance | Heritage Foods posted solid top-line growth but margin pressure from higher milk procurement costs led to a 39.5% YoY decline in PAT, while EBITDA margin improved sequentially. Evidence summary ready | |
| GTPL GTPL Hathway Limited Media · Small | Sept 2026 19 Oct 2026 Transcript verified | Bad 2/100 | Cautious outlook No comparable prior call New guidance | GTPL delivered strong top‑line growth driven by subscriber additions and the ACT acquisition, but profitability remained weak with a negative PAT and a decline in operating EBITDA margin, highlighting the need for integration synergies and margin recovery. Evidence summary ready | |
| POLYCAB Polycab India Limited Industrials · Mid | Sept 2026 19 Oct 2026 Transcript verified | Good 72/100 | Neutral outlook Broadly unchanged Guidance maintained | Polycab delivered record revenue and profit growth in Q2 FY27, driven by strong demand across wires & cables and FMEG segments, while management reiterated an unchanged outlook despite macro‑headwinds and noted exposure to commodity and logistics risks. Evidence summary ready | |
| TATAELXSI Tata Elxsi Limited IT · Mid | Sept 2026 19 Oct 2026 Transcript verified | Average 45/100 | Optimistic outlook Broadly unchanged No measurable guidance | Tata Elxsi reported Q2 FY27 operating revenue of INR 1055.7 crores (up 2.3% QoQ in constant currency) and an EBITDA margin of 21.9%, absorbing annual wage hikes through operational leverage and realization of one-offs. While US and India markets performed well, Europe remains soft and sluggish, particularly in automotive. Management expects an upward margin trajectory and better second-half performance compared to the first half. Evidence summary ready | |
| ICICIGI ICICI Lombard General Insurance Company Limited Financial Services · Mid | Sept 2026 19 Oct 2026 Transcript filed | Result pending No matching current-quarter result row | Outlook pending No comparable prior call Guidance pending | The available source has not produced sufficient structured evidence. Summary pending | |
| TATATECH Tata Technologies Limited IT · Small | Sep 2026 19 Oct 2026 Transcript verified | Average 32/100 | Optimistic outlook Weakened vs prior call No measurable guidance | Tata Technologies delivered solid revenue growth and maintained operating margin despite salary headwinds, but sequential PAT declined and technology solutions revenue fell due to accounting changes. Evidence summary ready | |
| KARURVYSYA Karur Vysya Bank Limited Financial Services · Small | Sep 2026 19 Oct 2026 Transcript verified | Excellent 75/100 | Optimistic outlook No comparable prior call Guidance maintained | Karur Vysya Bank delivered strong revenue and profit growth in Q2 FY26-27, with business expansion and robust CASA inflows, while maintaining NIM above guidance; management signals cautious but optimistic outlook for FY26-27 growth of 18-20% and highlights competitive pressure on margins. Evidence summary ready | |
| IOLCP IOL Chemicals and Pharmaceuticals Limited Industrials · Small | Sep 2026 19 Oct 2026 Transcript filed | Result pending No matching current-quarter result row | Outlook pending No comparable prior call Guidance pending | The available source has not produced sufficient structured evidence. Summary pending | |
| TEMPSENS Tempsens Instruments (India) Limited Industrials · Micro | Sep 2026 19 Oct 2026 Transcript filed | Result pending No matching current-quarter result row | Outlook pending No comparable prior call Guidance pending | The available source has not produced sufficient structured evidence. Summary pending | |
| METROPOLIS Metropolis Healthcare Limited Pharma · Micro | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call No measurable guidance | Management projects continued profitable and sustainable growth, leveraging technology, science, and network expansion. Focus on specialty tests, TruHealth, and D2C channels, alongside strategic M&A, aims to outpace industry growth and create shareholder value. Evidence summary ready | |
| EUROPRATIK Euro Pratik Sales Limited Industrials · Small | Sep 2026 19 Oct 2026 Transcript filed | Result pending No matching current-quarter result row | Outlook pending No comparable prior call Guidance pending | The available source has not produced sufficient structured evidence. Summary pending | |
| POLICYBZR PB Fintech Limited Financial Services · Mid | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Neutral outlook No comparable prior call No measurable guidance | The proposed regulatory updates pose a material threat to PB Fintech's general insurance revenue and current operating model, necessitating substantial cost rationalization and strategic pivots. The long-term impact hinges on the final regulatory framework and the company's ability to monetize new services or business models like MGA. Evidence summary ready | |
| NOVARTIND Novartis India Limited Pharma · Small | Sep 2026 19 Oct 2026 Transcript filed | Result pending No matching current-quarter result row | Outlook pending No comparable prior call Guidance pending | The available source has not produced sufficient structured evidence. Summary pending | |
| INDOBORAX Indo Borax & Chemicals Limited Industrials · Small | Sep 2026 19 Oct 2026 Transcript filed | Result pending No matching current-quarter result row | Outlook pending No comparable prior call Guidance pending | The available source has not produced sufficient structured evidence. Summary pending | |
| HTEL Hy-Tech Engineers Limited Industrials · Micro | Sep 2026 19 Oct 2026 Transcript filed | Result pending No matching current-quarter result row | Outlook pending No comparable prior call Guidance pending | The available source has not produced sufficient structured evidence. Summary pending | |
| INDIGOPNTS Indigo Paints Limited Consumer · Micro | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Bullish outlook No comparable prior call No measurable guidance | The company delivered robust Q1 FY27 results, exceeding sector growth with double-digit volume and value expansion across all product categories. Margin expansion was driven by operational leverage and cost control. Management aims for more aggressive top-line growth, even if it impacts short-term margins, and new capacity is coming online for the festive season. Evidence summary ready | |
| SHANKESH Shankesh Jewellers Limited Consumer · Micro | Sep 2026 19 Oct 2026 Transcript filed | Result pending No matching current-quarter result row | Outlook pending No comparable prior call Guidance pending | The available source has not produced sufficient structured evidence. Summary pending | |
| PARKHOTELS Apeejay Surrendra Park Hotels Limited Consumer · Small | Sep 2026 19 Oct 2026 Transcript filed | Result pending No matching current-quarter result row | Outlook pending No comparable prior call Guidance pending | The available source has not produced sufficient structured evidence. Summary pending | |
| XTGLOBAL Xtglobal Infotech Limited IT · Small | Sep 2026 19 Oct 2026 Transcript filed | Result pending No matching current-quarter result row | Outlook pending No comparable prior call Guidance pending | The available source has not produced sufficient structured evidence. Summary pending | |
| FORTIS Fortis Healthcare Limited Pharma · Mid | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Neutral outlook No comparable prior call No measurable guidance | The Delhi High Court's order for a forensic audit into past transactions, including IHH's primary share issuance, creates a significant legal overhang. While management asserts no operational impact and full compliance, the 6-month audit timeline and potential for further litigation prolong uncertainty, diverting management focus and potentially impacting brand perception. Evidence summary ready | |
| HORIZONIND Horizon Industrial Parks Limited Real Estate · Small | Sep 2026 19 Oct 2026 Transcript filed | Result pending No matching current-quarter result row | Outlook pending No comparable prior call Guidance pending | The available source has not produced sufficient structured evidence. Summary pending | |
| GAJA Gaja Alternative Asset Management Limited Financial Services · Micro | Sep 2026 19 Oct 2026 Transcript filed | Result pending No matching current-quarter result row | Outlook pending No comparable prior call Guidance pending | The available source has not produced sufficient structured evidence. Summary pending | |
| SKYWAYS Skyways Air Services Limited Services · Micro | Sep 2026 19 Oct 2026 Transcript filed | Result pending No matching current-quarter result row | Outlook pending No comparable prior call Guidance pending | The available source has not produced sufficient structured evidence. Summary pending | |
| ASTERDM Aster DM Healthcare Limited Pharma · Small | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook Broadly unchanged No measurable guidance | The successful merger and strong proforma FY2026 results, coupled with clear strategic priorities for integration and network expansion, suggest the company is on track to leverage scale and clinical depth. Management's focus on capital efficiency and margin improvement supports the long-term value creation thesis. Evidence summary ready | |
| HAPPSTMNDS Happiest Minds Technologies Limited IT · Micro | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call No measurable guidance | The proposed merger with ITC Infotech fundamentally alters Happiest Minds' standalone investment thesis. While aiming for significant scale and accelerated revenue targets, the combined entity introduces new integration risks, governance structures, and a re-evaluation of valuation metrics. The success hinges on disciplined execution of integration and synergy realization. Evidence summary ready | |
| ESDS ESDS Software Solution Limited IT · Small | Sep 2026 19 Oct 2026 Transcript filed | Result pending No matching current-quarter result row | Outlook pending No comparable prior call Guidance pending | The available source has not produced sufficient structured evidence. Summary pending | |
| UJJIVANSFB Ujjivan Small Finance Bank Limited Financial Services · Micro | Sep 2026 19 Oct 2026 Transcript verified | Excellent 85/100 | Optimistic outlook No comparable prior call Guidance maintained | Ujjivan Small Finance Bank announced the early retirement of its MD & CEO due to health reasons and appointed Ms. Carol Furtado as Interim MD & CEO. Management reassured stakeholders of continuity in strategy, strong governance, and commitment to FY27 guidance, emphasizing that growth plans and capital adequacy remain unaffected by the leadership transition or potential delays in capital raising. The search for a permanent MD & CEO has been expedited. Evidence summary ready | |
| IDEA Vodafone Idea Limited Telecom · Mid | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Bullish outlook No comparable prior call No measurable guidance | The company delivered its first quarter of positive net subscriber additions since the merger, alongside strong ARPU growth and improved profitability. Initial funding tranches and credit rating upgrades are positive, but the large capex plan requires significant further debt mobilization. Execution on network rollout and sustained subscriber growth are critical. Evidence summary ready | |
| SRGHFL SRG Housing Finance Limited Financial Services · Small | Sep 2026 19 Oct 2026 Transcript filed | Result pending No matching current-quarter result row | Outlook pending No comparable prior call Guidance pending | The available source has not produced sufficient structured evidence. Summary pending | |
| RACLGEAR RACL Geartech Limited IT · Small | Sep 2026 19 Oct 2026 Transcript filed | Result pending No matching current-quarter result row | Outlook pending No comparable prior call Guidance pending | The available source has not produced sufficient structured evidence. Summary pending | |
| URBANCO Urban Company Limited Consumer · Small | Sep 2026 17 Oct 2026 Transcript verified | Bad 22/100 | Optimistic outlook No comparable prior call Guidance maintained | Urban Company reported strong growth across its core businesses, with consolidated NTV up 39.1% YoY and revenue up 41.4% YoY. The core businesses (India Consumer Services, International, Native) are showing significant operating leverage and margin expansion, leading to a positive adjusted EBITDA of ₹30 crores excluding InstaHelp. However, consolidated results reflect a substantial ₹174 crore investment in InstaHelp, which remains a strategic focus for long-term market leader Evidence summary ready | |
| CANBK Canara Bank Financial Services · Large | Sept 2026 17 Oct 2026 Transcript filed | Average 50/100 | Outlook pending No comparable prior call Guidance pending | The available source has not produced sufficient structured evidence. Summary pending |